Immunohistochemical Evaluation of Perlecan (Heparan Sulphate Proteoglycan 2) Expression in Invasive Female Breast Carcinoma.

Asian Pac J Cancer Prev · 2023 · PMC10909087 · PMID 38156864

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In conclusion, although Perlecan immunohistochemical expression did not reach statistical significance with any of the studied parameters, we observed higher expression in cases with poor prognostic factors, including high grade, more advanced stage with nodal metastasis and LVI, as well as cases with Her2 neu overexpression and higher Ki-67 proliferation index.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.